Neither metoprolol nor diltiazem is universally better. They work through completely different mechanisms, and the right choice depends on your specific condition, other health issues, and what medications you already take. For atrial fibrillation with a rapid heart rate, both are roughly equally effective at bringing the rate under control. For stable angina, diltiazem has a slight edge in exercise tolerance. For people with heart failure, metoprolol is generally the safer pick.
How Each Drug Works
Metoprolol is a beta-blocker. It reduces your heart’s response to adrenaline by blocking receptors on heart muscle cells, which slows both the rate and force of each heartbeat. It’s “cardioselective,” meaning it primarily targets the heart rather than other organs like the lungs or blood vessels, though at higher doses that selectivity fades.
Diltiazem is a calcium channel blocker. It works by directly blocking calcium from entering heart and blood vessel cells, which relaxes blood vessel walls and slows electrical conduction through the heart. Because it acts on both the heart and blood vessels, diltiazem tends to lower blood pressure more noticeably and can also relieve spasm in the coronary arteries.
Atrial Fibrillation Rate Control
Both drugs are standard options for slowing a fast heart rate caused by atrial fibrillation. In emergency settings, diltiazem is often the first choice because it works quickly through an IV and reliably brings the heart rate below 100 beats per minute. A study of patients who had both atrial fibrillation and reduced heart function found that metoprolol and diltiazem were equally able to achieve rate control within 30 minutes of the first dose, and both maintained similar results at 60 and 120 minutes.
The key difference shows up when heart failure is part of the picture. Metoprolol has long-term survival benefits in heart failure that diltiazem does not. Diltiazem can actually worsen heart failure in some patients because its blood vessel relaxation and negative effects on heart muscle contraction compound the problem. If you have a weak heart pump, your doctor will almost certainly lean toward metoprolol or another beta-blocker for ongoing rate control.
Angina and Chest Pain
For stable angina, both medications reduce the number of weekly chest pain episodes by a similar amount. In one controlled trial, patients went from about five anginal attacks per week on placebo down to roughly one per week on either drug. Where diltiazem pulled ahead was exercise capacity: patients on diltiazem gained an average of 1.2 minutes of exercise time compared to just 0.4 minutes with metoprolol, a statistically significant difference.
That advantage makes sense given how each drug works. Diltiazem relaxes coronary arteries directly, improving blood flow to the heart muscle during exertion. Metoprolol reduces the heart’s oxygen demand by slowing it down but doesn’t open the arteries themselves. If your angina involves coronary artery spasm rather than fixed blockages, diltiazem is typically the stronger choice.
Blood Pressure Lowering
Both medications lower blood pressure, but they do it differently. Metoprolol reduces blood pressure mainly by slowing the heart and decreasing its output. Diltiazem lowers it by relaxing the walls of your arteries. In practice, diltiazem tends to produce a more noticeable drop in blood pressure, which can be an advantage if your blood pressure runs high or a disadvantage if you’re already prone to dizziness or low readings.
Lung Disease and Asthma
This is one area where diltiazem has a clear advantage on paper, though the reality is more nuanced than many people assume. Beta-blockers have a reputation for triggering airway tightening in people with asthma or COPD, because blocking certain receptors in the lungs can cause the airways to constrict. Metoprolol, being cardioselective, is far less likely to do this than older, non-selective beta-blockers like propranolol.
Multiple meta-analyses have shown that cardioselective beta-blockers like metoprolol do not produce clinically significant breathing problems in patients with mild to moderate reactive airway disease. In studies of continued treatment, lung function measurements showed no meaningful decline compared to placebo, and patients didn’t need more rescue inhaler use. Long-term data showed no increase in respiratory emergencies, ER visits, or hospitalizations. Still, if you have severe or poorly controlled asthma, diltiazem avoids the lung issue entirely since calcium channel blockers don’t interact with airway receptors at all.
Side Effects to Expect
Metoprolol’s most common side effects are fatigue, cold hands and feet, and a slower-than-normal heart rate. Some people notice weight gain, sleep disturbances, or vivid dreams. Because it dampens your adrenaline response, it can also blunt your ability to feel the warning signs of low blood sugar if you have diabetes.
Diltiazem’s signature side effects are constipation, ankle swelling, and headache. The constipation can be persistent enough to require management on its own. Diltiazem can also cause a slow heart rate, though through a different mechanism than metoprolol. One important caution: combining the two drugs amplifies their effects on the heart’s electrical system and can lead to dangerously slow heart rates or heart block, so they’re rarely used together.
Drug Interactions
Diltiazem carries a heavier burden of drug interactions. It inhibits a liver enzyme responsible for breaking down many common medications, which means it can raise blood levels of those drugs to potentially dangerous concentrations. This includes several cholesterol-lowering statins (simvastatin and lovastatin in particular), certain sedatives, and a range of other medications. If you take multiple prescriptions, your pharmacist will need to review them carefully before starting diltiazem.
Metoprolol is also processed by liver enzymes, but it doesn’t significantly interfere with the metabolism of other drugs the way diltiazem does. Its interaction profile is simpler, which can matter if you’re on a complex medication regimen.
Choosing Between Them
The decision often comes down to what other conditions you have. Heart failure tips the scale toward metoprolol, which has proven survival benefits in that population. Coronary artery spasm or a need for better exercise tolerance in angina favors diltiazem. Severe asthma makes diltiazem the path of least resistance. Multiple other medications, especially statins, can make metoprolol the simpler choice from an interaction standpoint.
For straightforward atrial fibrillation rate control in an otherwise healthy person, the two drugs perform similarly, and the choice may come down to which side effect profile you tolerate better. Fatigue and cold extremities versus constipation and ankle swelling is a personal trade-off. Your response to either drug is also somewhat individual. Some people achieve excellent rate control on a low dose of one and need high doses of the other, so switching is always an option if the first choice doesn’t work well.